Green Cross Corp/South Korea
GC Biopharma Corp, formerly Green Cross Corp, is a South Korean biopharmaceutical company specializing in plasma-derived therapeutics and vaccines. The company manufactures plasma protein therapeutics including human serum albumin and immunoglobulins, influenza vaccines, chickenpox vaccines, and rare disease treatments. Main revenue drivers comprise domestic and export sales of plasma therapeutics, seasonal flu vaccines, diagnostic kits, and prescription pharmaceuticals. GC Biopharma serves hospitals, public health authorities, prescription pharmacies, and clinical medical centers across South Korea, North America, and emerging international markets. The company holds a market-leading domestic position as South Korea's premier supplier of plasma products and vaccines. Headquartered in Yongin, Gyeonggi Province, South Korea, it is listed on the Korea Exchange.
2 of the funds FundTelligence covers report a position in Green Cross Corp/South Korea.
- Sector
- Health Care
- Country
- South Korea
- Funds holding it
- 2
Funds holding Green Cross Corp/South Korea
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Indeks Nye Markeder — Storebrand · 0.0 % (full portfolio disclosed, October 2026)